Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Weak
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Telephone
61.3.9801.8888
Address
Boronia 45 Wadhurst Drive Melbourne, Victoria (VIC) 3155
Description
IDT Australia Ltd. produces, develops and supplies pharmaceutical products. It engages in the provision of research and development and other technical services for the pharmaceutical and allied industries. The company specializes in the post-discovery pharmaceutical life cycle. It also provides services through API manufacturing, new drug development and scale-up, clinical research services, pharmacy services and finished dosage forms to the pharmaceutical industry. IDT Australia was founded by Graeme Leslie Blackman on October 14, 1975 and is headquartered in Melbourne, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.05 - 0.14
Trade Value (12mth)
AU$8,115.00
1 week
0%
1 month
-4.17%
YTD
7.33%
1 year
93.55%
All time high
2.80
EPS 3 yr Growth
-276.10%
EBITDA Margin
-36.40%
Operating Cashflow
-$10m
Free Cash Flow Return
-40.40%
ROIC
-22.80%
Interest Coverage
N/A
Quick Ratio
1.10
Shares on Issue (Fully Dilluted)
357m
HALO Sector
Healthcare
Next Company Report Date
02-Sep-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
26 August 24 |
FY24 Appendix 4E and Annual Report
×
FY24 Appendix 4E and Annual Report |
26 August 24 |
FY24 Appendix 4G and Corporate Governance Statement
×
FY24 Appendix 4G and Corporate Governance Statement |
26 August 24 |
FY24 Full Year Profit Results
×
FY24 Full Year Profit Results |
26 August 24 |
FY24 Full Year Results Presentation
×
FY24 Full Year Results Presentation |
09 August 24 |
IDT Secures New Contract with Sanofi Australia
×
IDT Secures New Contract with Sanofi Australia |
30 July 24 |
Strong Q4 Pushes Full-Year Revenue Ahead of Guidance
×
Strong Q4 Pushes Full-Year Revenue Ahead of Guidance |
10 July 24 |
Completion of Entitlement Offer
×
Completion of Entitlement Offer |
10 July 24 |
Application for quotation of securities - IDT
×
Application for quotation of securities - IDT |
10 July 24 |
Change in substantial holding from SNC
×
Change in substantial holding from SNC |
27 June 24 |
Reminder of IDT Entitlement Offer Closing Date
×
Reminder of IDT Entitlement Offer Closing Date |
13 June 24 |
IDT Despatches Entitlement Offer Booklet
×
IDT Despatches Entitlement Offer Booklet |
11 June 24 |
Update on Indicative Proposal from Mynd
×
Update on Indicative Proposal from Mynd |
05 June 24 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
04 June 24 |
Entitlement Offer to Raise $7m
×
Entitlement Offer to Raise $7m |
04 June 24 |
Proposed issue of securities - IDT
×
Proposed issue of securities - IDT |
04 June 24 |
Cleansing Notice
×
Cleansing Notice |
04 June 24 |
Correction - Entitlement Offer To Raise $7m at 9c Per Share
×
Correction - Entitlement Offer To Raise $7m at 9c Per Share |
04 June 24 |
Update - Proposed issue of securities - IDT
×
Update - Proposed issue of securities - IDT |
31 May 24 |
Trading Halt
×
Trading Halt |
21 May 24 |
FY24 Market Update
×
FY24 Market Update |
06 May 24 |
Victorian Government Awards Key Grant to IDT
×
Victorian Government Awards Key Grant to IDT |
23 April 24 |
Q3 Update - Third Quarter Operating Revenue Jumps 48%
×
Q3 Update - Third Quarter Operating Revenue Jumps 48% |
16 April 24 |
IDT Secures contract with Sanofi Australia
×
IDT Secures contract with Sanofi Australia |
13 March 24 |
Becoming a substantial holder
×
Becoming a substantial holder |
21 February 24 |
1HFY24 Appendix 4D and Half Year Report
×
1HFY24 Appendix 4D and Half Year Report |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.